WO2000078933A3 - Nouvelles calpaines et leur utilisation - Google Patents
Nouvelles calpaines et leur utilisation Download PDFInfo
- Publication number
- WO2000078933A3 WO2000078933A3 PCT/EP2000/005261 EP0005261W WO0078933A3 WO 2000078933 A3 WO2000078933 A3 WO 2000078933A3 EP 0005261 W EP0005261 W EP 0005261W WO 0078933 A3 WO0078933 A3 WO 0078933A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- novel
- calpains
- capn11
- synthesis
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pregnancy & Childbirth (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL14694000A IL146940A0 (en) | 1999-06-18 | 2000-06-07 | Novel calpains and their use |
EP00945716A EP1185673A2 (fr) | 1999-06-18 | 2000-06-07 | Nouvelles calpaines et leur utilisation |
KR1020017016244A KR20020011140A (ko) | 1999-06-18 | 2000-06-07 | 신규 칼파인 및 그의 용도 |
BR0011721-8A BR0011721A (pt) | 1999-06-18 | 2000-06-07 | Polipeptìdeo, sequência de polinucleotìdeos, uso de um polipeptìdeo, processo para identificar compostos que inibem a atividade enzimática de um polipeptìdeo, e, uso de compostos |
CA002375477A CA2375477A1 (fr) | 1999-06-18 | 2000-06-07 | Nouvelles calpaines et leur utilisation |
SK1826-2001A SK18262001A3 (sk) | 1999-06-18 | 2000-06-07 | Kalpaíny a ich použitie |
JP2001505676A JP2003503023A (ja) | 1999-06-18 | 2000-06-07 | 新規カルパインおよびその使用 |
MXPA01012937A MXPA01012937A (es) | 1999-06-18 | 2000-06-07 | Calpainas novedosas y su uso. |
AU59706/00A AU5970600A (en) | 1999-06-18 | 2000-06-07 | Novel calpains and their use |
NO20015922A NO20015922L (no) | 1999-06-18 | 2001-12-04 | Nye calpainer og anvendelse derav |
BG106186A BG106186A (bg) | 1999-06-18 | 2001-12-06 | Нови калпаини и използването им |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19928021.5 | 1999-06-18 | ||
DE19928021A DE19928021A1 (de) | 1999-06-18 | 1999-06-18 | Neue Calpaine und deren Verwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000078933A2 WO2000078933A2 (fr) | 2000-12-28 |
WO2000078933A3 true WO2000078933A3 (fr) | 2001-07-26 |
Family
ID=7911777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/005261 WO2000078933A2 (fr) | 1999-06-18 | 2000-06-07 | Nouvelles calpaines et leur utilisation |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1185673A2 (fr) |
JP (1) | JP2003503023A (fr) |
KR (1) | KR20020011140A (fr) |
CN (1) | CN1373808A (fr) |
AR (1) | AR024573A1 (fr) |
AU (1) | AU5970600A (fr) |
BG (1) | BG106186A (fr) |
BR (1) | BR0011721A (fr) |
CA (1) | CA2375477A1 (fr) |
DE (1) | DE19928021A1 (fr) |
HU (1) | HUP0201800A2 (fr) |
IL (1) | IL146940A0 (fr) |
MX (1) | MXPA01012937A (fr) |
NO (1) | NO20015922L (fr) |
PL (1) | PL353004A1 (fr) |
SK (1) | SK18262001A3 (fr) |
TR (1) | TR200103662T2 (fr) |
WO (1) | WO2000078933A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7101700A (en) | 1999-09-02 | 2001-03-26 | Lexicon Genetics Incorporated | Human calcium dependent proteases and polynucleotides encoding the same |
EP2563446A1 (fr) | 2010-04-30 | 2013-03-06 | Abbott Cardiovascular Systems Inc. | Cathéter à ballonnet amélioré se gonflant et se dégonflant rapidement |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19737105A1 (de) * | 1997-08-26 | 1999-03-04 | Basf Ag | Neue gewebsspezifische Calpaine, ihre Herstellung und Verwendung |
WO2000058473A2 (fr) * | 1999-03-31 | 2000-10-05 | Curagen Corporation | Acides nucleiques comprenant des phases de lecture ouverte codant des polypeptides; «orfx» |
-
1999
- 1999-06-18 DE DE19928021A patent/DE19928021A1/de not_active Withdrawn
-
2000
- 2000-06-07 KR KR1020017016244A patent/KR20020011140A/ko not_active Application Discontinuation
- 2000-06-07 MX MXPA01012937A patent/MXPA01012937A/es unknown
- 2000-06-07 SK SK1826-2001A patent/SK18262001A3/sk unknown
- 2000-06-07 TR TR2001/03662T patent/TR200103662T2/xx unknown
- 2000-06-07 HU HU0201800A patent/HUP0201800A2/hu unknown
- 2000-06-07 AU AU59706/00A patent/AU5970600A/en not_active Abandoned
- 2000-06-07 JP JP2001505676A patent/JP2003503023A/ja active Pending
- 2000-06-07 BR BR0011721-8A patent/BR0011721A/pt not_active IP Right Cessation
- 2000-06-07 CA CA002375477A patent/CA2375477A1/fr not_active Abandoned
- 2000-06-07 CN CN00808932A patent/CN1373808A/zh active Pending
- 2000-06-07 EP EP00945716A patent/EP1185673A2/fr not_active Withdrawn
- 2000-06-07 PL PL00353004A patent/PL353004A1/xx unknown
- 2000-06-07 WO PCT/EP2000/005261 patent/WO2000078933A2/fr not_active Application Discontinuation
- 2000-06-07 IL IL14694000A patent/IL146940A0/xx unknown
- 2000-06-16 AR ARP000102995A patent/AR024573A1/es unknown
-
2001
- 2001-12-04 NO NO20015922A patent/NO20015922L/no not_active Application Discontinuation
- 2001-12-06 BG BG106186A patent/BG106186A/bg unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19737105A1 (de) * | 1997-08-26 | 1999-03-04 | Basf Ag | Neue gewebsspezifische Calpaine, ihre Herstellung und Verwendung |
WO2000058473A2 (fr) * | 1999-03-31 | 2000-10-05 | Curagen Corporation | Acides nucleiques comprenant des phases de lecture ouverte codant des polypeptides; «orfx» |
Non-Patent Citations (2)
Title |
---|
DEAR T NEIL ET AL: "CAPN11: A calpain with high mRNA levels in testis and located on chromosome 6.", GENOMICS, vol. 59, no. 2, 15 July 1999 (1999-07-15), pages 243 - 247, XP002159274, ISSN: 0888-7543 * |
ZHANG WENLI ET AL: "The major calpain isozymes are long-lived proteins. Design of an antisense strategy for calpain depletion in cultured cells.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 271, no. 31, 1996, pages 18825 - 18830, XP002159273, ISSN: 0021-9258 * |
Also Published As
Publication number | Publication date |
---|---|
NO20015922D0 (no) | 2001-12-04 |
HUP0201800A2 (en) | 2002-09-28 |
IL146940A0 (en) | 2002-08-14 |
SK18262001A3 (sk) | 2002-09-10 |
AR024573A1 (es) | 2002-10-16 |
BR0011721A (pt) | 2002-03-05 |
CN1373808A (zh) | 2002-10-09 |
NO20015922L (no) | 2002-02-12 |
AU5970600A (en) | 2001-01-09 |
EP1185673A2 (fr) | 2002-03-13 |
PL353004A1 (en) | 2003-09-22 |
CA2375477A1 (fr) | 2000-12-28 |
WO2000078933A2 (fr) | 2000-12-28 |
MXPA01012937A (es) | 2002-07-30 |
DE19928021A1 (de) | 2000-12-21 |
JP2003503023A (ja) | 2003-01-28 |
KR20020011140A (ko) | 2002-02-07 |
BG106186A (bg) | 2002-12-29 |
TR200103662T2 (tr) | 2002-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200205479B (en) | Novel biarylcarboxamides. | |
ZA9610687B (en) | Novel synthesis. | |
AU6041998A (en) | Novel prostate-associated kallikrein | |
AU1378500A (en) | Novel pyrimidines, the production thereof and their use | |
ZA964710B (en) | Novel compounds, the preparation and use thereof. | |
AU1923095A (en) | Novel integrin alpha subunit | |
ZA991272B (en) | Novel thiobenzamides. | |
EP1254140A4 (fr) | Composes de la serie saframycine-ecteinascidine, utilisations et synthese | |
WO1999054315A3 (fr) | Triazolones a effet neuroprotecteur | |
ZA99473B (en) | New naphthyl- and anilide-substituted sulphonamides. | |
ZA98387B (en) | Novel microorganisms. | |
MXPA03001991A (es) | Novedosas arilalcano-sulfonamidas. | |
ZA974084B (en) | Novel α-glucuronidases, production hereof and their uses. | |
CA2369825A1 (fr) | Composants microstructures | |
MXPA02001614A (es) | Factor de transcripcion novedoso, bp1. | |
AU7476900A (en) | 26176, a novel calpain protease and uses thereof | |
MXPA02000261A (es) | Aminoindanos novedosos. | |
MXPA03002926A (es) | Proceso para la sintesis de 2,2,6,6,-tetrametil-4--oxipiperidina. | |
WO2000078933A3 (fr) | Nouvelles calpaines et leur utilisation | |
USD480416S1 (en) | Trainee pad | |
AU2001270603A1 (en) | Calpain protease 12 | |
USD508943S1 (en) | Type font | |
AU2001241770A1 (en) | 18036, a novel calpain-like protease and uses thereof | |
AU2002217276A1 (en) | Novel polymerisation catalysts | |
AU2094101A (en) | Leukolysin/mmp25/mt6-mmp |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 00808932.9 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200109927 Country of ref document: ZA |
|
ENP | Entry into the national phase |
Ref document number: 2000 106186 Country of ref document: BG Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2375477 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 18262001 Country of ref document: SK |
|
WWE | Wipo information: entry into national phase |
Ref document number: 516189 Country of ref document: NZ Ref document number: PA/a/2001/012937 Country of ref document: MX Ref document number: 2000945716 Country of ref document: EP Ref document number: IN/PCT/2001/1765/CHE Country of ref document: IN Ref document number: 2001/03662 Country of ref document: TR |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2001-4540 Country of ref document: CZ |
|
ENP | Entry into the national phase |
Ref document number: 2001 505676 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017016244 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: P20020043A Country of ref document: HR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 59706/00 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2002 2002101018 Country of ref document: RU Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017016244 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2000945716 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2001-4540 Country of ref document: CZ |
|
WWR | Wipo information: refused in national office |
Ref document number: 1020017016244 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000945716 Country of ref document: EP |